Skip to main content
logo
X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
2.830
0.00 (0.00%)
At close: Oct 2, 2026, 4:00 PM EDT
2.800
-0.030 (-1.06%)
After-hours: Oct 2, 2026, 7:30 PM EDT

X4 Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
28135012514012164
Market Cap Growth
245.26%179.54%-10.81%16.23%87.36%-38.49%
Enterprise Value
15030568577928
Last Close Price
2.834.0022.0125.1629.7968.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.499.9648.93---
PB Ratio
1.751.885.652.751.631.00
P/TBV Ratio
2.222.19-4.162.131.37

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
9.248.6826.73---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.500.423.531.140.520.62
Net Debt / Equity Ratio
-0.84-0.94-1.08-1.09-1.12-0.65
Net Debt / EBITDA Ratio
1.662.240.170.520.950.56
Net Debt / FCF Ratio
1.562.050.180.581.080.59
Asset Turnover
0.090.160.02---
Inventory Turnover
0.681.58----
Quick Ratio
10.859.853.165.025.505.89
Current Ratio
11.3010.163.415.345.766.27
Return on Equity (ROE)
-113.08%-75.99%-102.26%-161.67%-135.58%-129.28%
Return on Assets (ROA)
-28.15%-22.86%-60.18%-44.38%-40.36%-39.24%
Return on Capital Employed (ROCE)
-34.50%-30.20%-124.50%-86.40%-66.10%-73.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-32.53%-22.64%-29.93%-72.12%-77.78%-137.70%
FCF Yield
-30.22%-24.48%-104.89%-68.84%-63.97%-111.04%
Buyback Yield / Dilution
-1374.07%-531.04%-13.08%-179.91%-146.71%-28.25%
SEC Filings: 10-K · 10-Q